A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe against cancer program

Hiromichi Matsushita; Miki Yamamoto; Kosuke Tsuboi; Atsuko Masukawa; Satoshi Arakawa; Satomi Asai; Yoshiaki Ogawa; Kiyoshi Ando; Hayato Miyachi

doi:10.1515/CCLM.2009.202

A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe against cancer program

Hiromichi Matsushita, Miki Yamamoto, Kosuke Tsuboi, Atsuko Masukawa, Satoshi Arakawa, Satomi Asai, Yoshiaki Ogawa, Kiyoshi Ando, Hayato Miyachi

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	885-887
Number of pages	3
Journal	Clinical Chemistry and Laboratory Medicine
Volume	47
Issue number	7
DOIs	https://doi.org/10.1515/CCLM.2009.202
Publication status	Published - 2009 Jul 1
Externally published	Yes

Keywords

BCR-ABL1
Chronic myelogenous leukemia (CML)
Real-time quantitative polymerase chain reaction (RQ-PCR)
The Europe Against Cancer (EAC) Program

ASJC Scopus subject areas

Clinical Biochemistry
Biochemistry, medical

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1515/CCLM.2009.202

Cite this

Matsushita, H., Yamamoto, M., Tsuboi, K., Masukawa, A., Arakawa, S., Asai, S., Ogawa, Y., Ando, K., & Miyachi, H. (2009). A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe against cancer program. Clinical Chemistry and Laboratory Medicine, 47(7), 885-887. https://doi.org/10.1515/CCLM.2009.202

A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe against cancer program. / Matsushita, Hiromichi; Yamamoto, Miki; Tsuboi, Kosuke et al.
In: Clinical Chemistry and Laboratory Medicine, Vol. 47, No. 7, 01.07.2009, p. 885-887.

Research output: Contribution to journal › Letter › peer-review

Matsushita, H, Yamamoto, M, Tsuboi, K, Masukawa, A, Arakawa, S, Asai, S, Ogawa, Y, Ando, K & Miyachi, H 2009, 'A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe against cancer program', Clinical Chemistry and Laboratory Medicine, vol. 47, no. 7, pp. 885-887. https://doi.org/10.1515/CCLM.2009.202

Matsushita H, Yamamoto M, Tsuboi K, Masukawa A, Arakawa S, Asai S et al. A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe against cancer program. Clinical Chemistry and Laboratory Medicine. 2009 Jul 1;47(7):885-887. doi: 10.1515/CCLM.2009.202

@article{d269503e63094a34b289924b4c980732,

title = "A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe against cancer program",

keywords = "BCR-ABL1, Chronic myelogenous leukemia (CML), Real-time quantitative polymerase chain reaction (RQ-PCR), The Europe Against Cancer (EAC) Program",

author = "Hiromichi Matsushita and Miki Yamamoto and Kosuke Tsuboi and Atsuko Masukawa and Satoshi Arakawa and Satomi Asai and Yoshiaki Ogawa and Kiyoshi Ando and Hayato Miyachi",

year = "2009",

month = jul,

day = "1",

doi = "10.1515/CCLM.2009.202",

language = "English",

volume = "47",

pages = "885--887",

journal = "Zeitschrift fur klinische Chemie und klinische Biochemie",

issn = "1434-6621",

publisher = "Walter de Gruyter GmbH & Co. KG",

number = "7",

}

TY - JOUR

T1 - A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe against cancer program

AU - Matsushita, Hiromichi

AU - Yamamoto, Miki

AU - Tsuboi, Kosuke

AU - Masukawa, Atsuko

AU - Arakawa, Satoshi

AU - Asai, Satomi

AU - Ogawa, Yoshiaki

AU - Ando, Kiyoshi

AU - Miyachi, Hayato

PY - 2009/7/1

Y1 - 2009/7/1

KW - BCR-ABL1

KW - Chronic myelogenous leukemia (CML)

KW - Real-time quantitative polymerase chain reaction (RQ-PCR)

KW - The Europe Against Cancer (EAC) Program

UR - http://www.scopus.com/inward/record.url?scp=67849089074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67849089074&partnerID=8YFLogxK

U2 - 10.1515/CCLM.2009.202

DO - 10.1515/CCLM.2009.202

M3 - Letter

C2 - 19575551

AN - SCOPUS:67849089074

SN - 1434-6621

VL - 47

SP - 885

EP - 887

JO - Zeitschrift fur klinische Chemie und klinische Biochemie

JF - Zeitschrift fur klinische Chemie und klinische Biochemie

IS - 7

ER -

A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe against cancer program

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this